Effects of miR-145 on the migration and invasion of prostate cancer PC3 cells by targeting DAB2
Received date: 2013-08-29
Revised date: 2013-09-29
Online published: 2013-12-20
It was reported that miR-145, which is significantly decreased in a variety of tumor cells, is associated with cell proliferation and metastasis. In this study, using bioinformatics analysis and in vitro assays, we identified DAB2 (Disabled homolog 2) as a downstream target gene of miR-145 during tumor metastasis process. DAB2 has been characterized as an important tumor suppressor, and is usually expressed at low levels in tumor cells. However, in this study, the relative high-level expression of DAB2 gene was observed in the highly invasive prostate cancer PC3 cells. Moreover, enforced expression of miR-145 could significantly down-regulate the expression level of DAB2 in PC3 cells, and inhibit the migration and invasion of PC3 cells. Notably, dysfunction of PC3 cells induced by miR-145 overexpression can be rescued by co-overexpression of DAB2. These results demonstrate that miR-145 regulates the migration and invasion of highly invasive prostate cancer cells through targeting DAB2 gene.
Key words： miR-145; DAB2; prostate cancer cell PC3; cell migration and invasion
Shugao Xie, Yinyin Xie, Yuanliang Zhang, Qiuhua Huang . Effects of miR-145 on the migration and invasion of prostate cancer PC3 cells by targeting DAB2[J]. Hereditas(Beijing), 2014 , 36(1) : 50 -57 . DOI: 10.3724/SP.J.1005.2014.00050
[1] Porkka KP, Pfeiffer MJ, Waltering KK, Vessella RL, Tammela TL, Visakorpi T. MicroRNA expression profiling in prostate cancer. Cancer Res, 2007, 67(13): 6130–6135. <\p>
[2] Ozen M, Creighton CJ, Ozdemir M, Ittmann M. Widespread deregulation of microRNA expression in human prostate cancer. Oncogene, 2008, 27(12): 1788–1793. <\p>
[3] Michael MZ, SM OC, Van Holst Pellekaan NG, Young GP, James RJ. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res, 2003, 1(12): 882–891. <\p>
[4] Takagi T, Iio A, Nakagawa Y, Naoe T, Tanigawa N, Akao Y. Decreased expression of microRNA-143 and -145 in human gastric cancers. Oncology, 2009, 77(1): 12–21. <\p>
[5] Akao Y, Nakagawa Y, Naoe T. MicroRNAs 143 and 145 are possible common onco-microRNAs in human cancers. Oncol Rep, 2006, 16(4): 845–850. <\p>
[6] Kano M, Seki N, Kikkawa N, Fujimura L, Hoshino I, Akutsu Y, Chiyomaru T, Enokida H, Nakagawa M, Mat-subara H. miR-145, miR-133a and miR-133b: Tu-mor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int J Cancer, 2010, 127(12): 2804–2814. <\p>
[7] Bandrés E, Cubedo E, Agirre X, Malumbres R, Zárate R, Ramirez N, Abajo A, Navarro A, Morenó I, Monzo M, García-Foncillas J. Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer, 2006, 5: 29. <\p>
[8] Chiyomaru T, Tatarano S, Kawakami K, Enokida H, Yo-shino H, Nohata N, Fuse M, Seki N, Nakagawa M. SWAP70, actin-binding protein, function as an oncogene targeting tumor-suppressive miR-145 in prostate cancer. Prostate, 2011, 71(14), doi: 10.1002/pros.21372. <\p>
[9] Chen H, Toyooka S, Gazdar AF, Hsieh JT. Epigenetic reg-ulation of a novel tumor suppressor gene (hDAB2IP) in prostate cancer cell lines. J Biol Chem, 2003, 278(5): 3121–3130. <\p>
[10] Dote H, Toyooka S, Tsukuda K, Yano M, Ouchida M, Doihara H, Suzuki M, Chen H, Hsieh JT, Gazdar AF, Shi-mizu N. Aberrant promoter methylation in human DAB2 interactive protein (hDAB2IP) gene in breast cancer. Clin Cancer Res, 2004, 10(6): 2082–2089. <\p>
[11] Dote H, Toyooka S, Tsukuda K, Yano M, Ota T, Murakami M, Naito M, Toyota M, Gazdar AF, Shimizu N. Aberrant promoter methylation in human DAB2 interactive protein (hDAB2IP) gene in gastrointestinal tumour. Br J Cancer, 2005, 92(6): 1117–1125. <\p>
[12] Yano M, Toyooka S, Tsukuda K, Dote H, Ouchida M, Ha-nabata T, Aoe M, Date H, Gazdar AF, Shimizu N. Aberrant promoter methylation of human DAB2 interactive protein (hDAB2IP) gene in lung cancers. Int J Cancer, 2005, 113(1): 59–66. <\p>
[13] Prunier C, Howe PH. Disabled-2 (Dab2) is required for transforming growth factor β-induced epithelial to me-senchymal transition (EMT). J Biol Chem, 2005, 280(17): 17540–17548. <\p>
[14] Jechlinger M, Grunert S, Tamir IH, Janda E, Lüdemann S, Waerner T, Seither P, Weith A, Beug H, Kraut N. Expression profiling of epithelial plasticity in tumor progression. Oncogene, 2003, 22(46): 7155–7169. <\p>
[15] Strizzi L, Bianco C, Normanno N, Seno M, Wechselberger C, Wallace-Jones B, Khan NI, Hirota M, Sun YP, Sanicola M, Salomon DS. Epithelial mesenchymal transition is a characteristic of hyperplasias and tumors in mammary gland from MMTV-Cripto-1 transgenic mice. J Cell Physiol, 2004, 201(2): 266–276. <\p>
[16] Yang JL, Du XL. Genomic and molecular aberrations in malignant peripheral nerve sheath tumor and their roles in personalized target therapy. Surg Oncol, 2013, 22(3): e53–e57. <\p>
[17] Chao A, Lin CY, Lee YS, Tsai CL, Wei PC, Hsueh S, Wu TI, Tsai CN, Wang CJ, Chao AS, Wang TH, Lai CH. Regulation of ovarian cancer progression by microRNA- 187 through ta
/
| 〈 |
|
〉 |
www.chinagene.cn
备案号：京ICP备09063187号
